Posted on

Going to Vision Expo West? Check out the QuantifEye MPS II

MPOD_being_used_07242014_LGAre you going to this year’s Vision Expo West? If so, stop by booth #25092! We’ll be featuring the new QuantifEye® MPS II macular pigment screener during this year’s conference in Las Vegas, Nevada to help raise awareness of the importance of measuring macular pigment to protect and support eye health and improve visual performance.

You can also take the MPOD challenge, win prizes, and contribute to a great cause.

Doctors can now measure a patient’s Macular Pigment Optical Density (MPOD) with more ease and less time thanks to our newly-released QuantifEye MPS II. The instrument, an update from the original QuantifEye measurement device, is the next generation in macular pigment measurement to help identify patients with low MPOD, a key risk factor for Age-related Macular Degeneration (AMD). AMD is a leading cause of severe vision loss in adults over the age of 55, affecting millions of Americans each year.

As for the challenge, a chance at winning some fabulous prizes, and the opportunity to help out an amazing optometry organization… You’ll have to stop by our booth to learn more!

The original QuantifEye, which debuted in 2006, has been scientifically validated for accuracy and repeatability in numerous clinical research studies. More than four-million eyes have been accurately measured by the QuantifEye instrument since market introduction. The new QuantifEye MPS II enhances the accuracy and reliability of the original QuantifEye instrument with significant software advancements that benefit the patient and optometric practice. The new technology is currently being installed in eye care practices across the nation.

QuantifEye MPS II Product Image